In the current study, by comparing the circulating T cells of HCC patients to the ones of healthy donors, we found that BTLA expressions of CD4+ T cells but not CD8+ T cells were significantly upregulated in HCC patients, whereas HVEM levels were significantly downregulated on circulating CD8+ rather than CD4+ T cells. The gene discussed is CD4; the disease is hepatocellular carcinoma.